IL17A and autoimmune hepatitis: Regarding emerging therapies being studied in autoimmune hepatitis, the most prominent themes we identified in our literature search relate to the balance between T cell activation, which can lead to production of IL-2 and IL-17, and suppressive responses, namely, the function of Tregs.